Zobrazeno 1 - 10
of 108 353
pro vyhledávání: '"Approval"'
Autor:
Rim MH; Northwestern Medicine, Chicago, IL, USA., Dean C; Northwestern Medicine, Chicago, IL, USA., Aliaj E; Northwestern Medicine, Chicago, IL, USA., Karas BL; Northwestern Medicine, Chicago, IL, USA., Barada F; Northwestern Medicine, Chicago, IL, USA., Levitsky AM; IPD Analytics, Aventura, FL, USA.
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2024 Nov 07; Vol. 81 (22), pp. 1103-1108.
Autor:
Mangia F; F.Hoffmann-La Roche, Grenzacherstrasse 124, Basel, 4058, Switzerland. francesca.mangia@roche.com., Lin YM; F.Hoffmann-La Roche, Grenzacherstrasse 124, Basel, 4058, Switzerland., Armando J; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Dominguez K; F.Hoffmann-La Roche, Grenzacherstrasse 124, Basel, 4058, Switzerland., Rozhnova V; F.Hoffmann-La Roche, Grenzacherstrasse 124, Basel, 4058, Switzerland., Ausborn S; F.Hoffmann-La Roche, Grenzacherstrasse 124, Basel, 4058, Switzerland.
Publikováno v:
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2024 Nov; Vol. 58 (6), pp. 997-1005. Date of Electronic Publication: 2024 Jul 24.
Autor:
Mohetaer M; School of Business Administration, Shenyang Pharmaceutical University, Shenyang, China., Tuersun A; School of Life Sciences and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, Liaoning, China., Li P; School of Business Administration, Shenyang Pharmaceutical University, Shenyang, China., Wang S; School of Business Administration, Shenyang Pharmaceutical University, Shenyang, China; Drug Regulatory Research Base of NMPA - Research Institute of Drug Regulatory Science, Shenyang Pharmaceutical University, Shenyang, China., Zhang X; School of Business Administration, Shenyang Pharmaceutical University, Shenyang, China; China Resources Sanjiu Medical & Pharmaceutical Co., Ltd, Shenzhen, China. Electronic address: xingyanz@yeah.net., Chen Y; School of Business Administration, Shenyang Pharmaceutical University, Shenyang, China; Drug Regulatory Research Base of NMPA - Research Institute of Drug Regulatory Science, Shenyang Pharmaceutical University, Shenyang, China. Electronic address: Chenyuwen@syphu.edu.cn.
Publikováno v:
Clinical therapeutics [Clin Ther] 2024 Dec; Vol. 46 (12), pp. 1059-1068. Date of Electronic Publication: 2024 Oct 05.
Autor:
Manski CF; Department of Economics and Institute for Policy Research, Northwestern University, Evanston, IL, USA. Electronic address: cfmanski@northwestern.edu.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2024 Dec; Vol. 27 (12), pp. 1637-1640. Date of Electronic Publication: 2024 Mar 26.
Autor:
Bhenderu LS; Department of Neurological Surgery, Houston Methodist Hospital, Houston, Texas, USA lokeshwar.bhenderu@gmail.com.; Clinical Innovations Laboratory, Houston Methodist Research Institute, Houston, Texas, USA.; Center for Translational Neural Prosthetics and Interfaces, Houston Methodist Research Institute, Houston, Texas, USA., Hardigan T; Department of Neurological Surgery, Icahn School of Medicine at Mount Sinai Hospital, New York, New York, USA., Roa J; Department of Neurological Surgery, Icahn School of Medicine at Mount Sinai Hospital, New York, New York, USA., Philbrick BD; Department of Neurological Surgery, Icahn School of Medicine at Mount Sinai Hospital, New York, New York, USA., Hoang A; Department of Neurological Surgery, Houston Methodist Hospital, Houston, Texas, USA.; Center for Translational Neural Prosthetics and Interfaces, Houston Methodist Research Institute, Houston, Texas, USA., Faraji AH; Department of Neurological Surgery, Houston Methodist Hospital, Houston, Texas, USA.; Clinical Innovations Laboratory, Houston Methodist Research Institute, Houston, Texas, USA.; Center for Translational Neural Prosthetics and Interfaces, Houston Methodist Research Institute, Houston, Texas, USA., Britz GW; Department of Neurological Surgery, Houston Methodist Hospital, Houston, Texas, USA.; Center for Translational Neural Prosthetics and Interfaces, Houston Methodist Research Institute, Houston, Texas, USA., Yaeger KA; Department of Neurological Surgery, Houston Methodist Hospital, Houston, Texas, USA.; Clinical Innovations Laboratory, Houston Methodist Research Institute, Houston, Texas, USA.; Center for Translational Neural Prosthetics and Interfaces, Houston Methodist Research Institute, Houston, Texas, USA.
Publikováno v:
Journal of neurointerventional surgery [J Neurointerv Surg] 2024 Nov 22; Vol. 16 (12), pp. 1216-1219. Date of Electronic Publication: 2024 Nov 22.
Autor:
Kuribayashi R; Office of Cellular and Tissue-Based Products, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-Ku, Tokyo, 100-0013, Japan. kuribayashi-ryosuke@pmda.go.jp.; Office of Regulatory Science Research, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-Ku, Tokyo, 100-0013, Japan. kuribayashi-ryosuke@pmda.go.jp., Goto K; Office of Cellular and Tissue-Based Products, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-Ku, Tokyo, 100-0013, Japan., Ogawa T; Office of Generic Drugs, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-Ku, Tokyo, 100-0013, Japan.
Publikováno v:
The AAPS journal [AAPS J] 2024 Nov 12; Vol. 26 (6), pp. 113. Date of Electronic Publication: 2024 Nov 12.
Autor:
Domike R; Light Pharma Inc, Cambridge, Massachusetts, USA. reuben.domike@lightpharma.com.; M.I.T. Center for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. reuben.domike@lightpharma.com.; University of Prince Edward Island, Charlottetown, PE, Canada. reuben.domike@lightpharma.com., Raju GK; Light Pharma Inc, Cambridge, Massachusetts, USA.; M.I.T. Center for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Sullivan J; EveryLife Foundation for Rare Diseases, Washington, DC, USA., Kennedy A; EveryLife Foundation for Rare Diseases, Washington, DC, USA.
Publikováno v:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2024 Nov 08; Vol. 19 (1), pp. 418. Date of Electronic Publication: 2024 Nov 08.
Autor:
Stoelinga J; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; School of Pharmacy, Utrecht University, Utrecht, the Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Russo M; Department of Statistics, the Ohio State University, Columbus, OH, USA., Kesselheim AS; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Feldman WB; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: wbfeldman@bwh.harvard.edu.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Nov; Vol. 212, pp. 114330. Date of Electronic Publication: 2024 Sep 12.
Autor:
Michaeli JC; Department of Obstetrics and Gynaecology, LMU University Hospital, LMU Munich, Munich, Germany., Michaeli T; Department of Personalized Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany.; Division of Personalized Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Trapani D; European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hematology, University of Milan, Milan, Italy., Albers S; Department of Orthopaedics and Sport Orthopaedics, School of Medicine, Klinikum Rechts Der Isar, Technical University of Munich, Munich, Germany., Dannehl D; Department of Women's Health, Tuebingen University Hospital, Tübingen, Germany., Würstlein R; Department of Obstetrics and Gynaecology, LMU University Hospital, LMU Munich, Munich, Germany., Michaeli DT; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. danielmichaeli@yahoo.com.
Publikováno v:
Breast cancer (Tokyo, Japan) [Breast Cancer] 2024 Nov; Vol. 31 (6), pp. 1144-1155. Date of Electronic Publication: 2024 Sep 25.
Autor:
Ishibashi K; Pharmaceuticals and Medical Devices Agency, Tokyo, Japan. ishibashi-kenichi@pmda.go.jp., Kondoh M; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan., Kusakabe T; Japan Agency for Medical Research and Development, Tokyo, Japan. tetsuya-kusakabe@amed.go.jp.
Publikováno v:
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2024 Nov; Vol. 58 (6), pp. 1172-1179. Date of Electronic Publication: 2024 Aug 30.